title: Decreased thermal denaturation temperature of osteogenesis imperfecta mutant collagen is independent of post-translational overmodifications of lysine and hydroxylysine.
abstract: Fibroblasts from many patients with osteogenesis imperfecta (OI) synthesize and secrete Type I collagen which is both overmodified and exhibits a decreased thermal denaturation temperature. We have examined the relationship between overmodification and decreased melting temperature in several favorable OI mutants by selectively inhibiting lysyl hydroxylase activity with the drug Minoxidil and comparing the melting profiles of the resultant undermodified collagen with untreated control. Minoxidil treatment causes an appreciable decrease in hydroxylysine with compensatory increases in lysine content, and the delayed sodium dodecyl sulfate-polyacrylamide gel electrophoretic mobility of the overmodified collagen chains becomes normal. However, the decreased melting temperature was unchanged from untreated OI control. When unhydroxylated collagen produced by normal control and OI fibroblasts incubated with alpha,alpha'-dipyridyl was examined, mutant OI molecules melted at a lower temperature than control. These data indicate that the decreased thermal denaturation temperature of OI mutant collagen is independent of post-translational overmodification of lysine or hydroxylysine. Presumably, substitutions for glycine in the Gly-X-Y structural motif distort the helix and produce lower melting temperatures by presently unknown mechanisms.
authors.affiliation: Research Department, Shriners Hospital for Crippled Children, Portland, Oregon 97201.
authors.forename: V H
authors.initials: VH
authors.lastname: Rao
authors.forename: B
authors.initials: B
authors.lastname: Steinmann
authors.forename: W
authors.initials: W
authors.lastname: de Wet
authors.forename: D W
authors.initials: DW
authors.lastname: Hollister
mesh_terms: D003094:Collagen / Q000235:genetics*; D006358:Hot Temperature; D006801:Humans; D006901:Hydroxylysine / Q000378:metabolism*; D008239:Lysine / Q000378:metabolism*; D008914:Minoxidil / Q000494:pharmacology; D009154:Mutation; D010013:Osteogenesis Imperfecta / Q000235:genetics* / Q000378:metabolism; D010434:Pepsin A / Q000378:metabolism; D011499:Protein Processing, Post-Translational
chemical_list: D006901:Hydroxylysine; D008914:Minoxidil; D003094:Collagen; D010434:Pepsin A; D008239:Lysine